---
schema_version: "secwatch.filing_event.v1"
accession: "0001193805-21-001455"
form_type: "8-K"
ticker: "IMUX"
cik: "0001280776"
company_name: "IMMUNIC, INC."
filed_at: "2021-10-15T23:59:59+00:00"
generated_at: "2026-06-28T20:29:08.612739+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Immunic appoints Patrick Walsh as Chief Business Officer; $380K salary, 120K options

## Summary
- Patrick Walsh appointed Chief Business Officer, effective Oct 14, 2021.
- Base salary $380,000, signing bonus $60,000, options for 120,000 shares.
- Options vest 25% on first anniversary, then monthly over 36 months; target bonus min 35%.
- Severance: 12 months' base salary on termination without cause; 33% equity vesting (100% near change of control).
- Previously VP Business Development at Akebia Therapeutics; earlier roles at AVEO, Capgemini, Leerink.

## SEC filing metadata
- accession: 0001193805-21-001455
- form_type: 8-K
- ticker: IMUX
- cik: 0001280776
- company_name: IMMUNIC, INC.
- filed_at: 2021-10-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1280776/000119380521001455/0001193805-21-001455-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1280776/000119380521001455/e621010_8k-immunic.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193805-21-001455
- JSON: https://secwatch.observer/filing/0001193805-21-001455.json
- Plain text: https://secwatch.observer/filing/0001193805-21-001455.txt

## Key facts
- Executive change
  Patrick Walsh was appointed as Chief Business Officer at IMMUNIC, INC..
  - Action: appointed
  - Role: Chief Business Officer
  source text: On October 14, 2021, the board of directors (the “Board”) of Immunic, Inc. (the “Company”) appointed Patrick Walsh as the Chief Business Officer, effective October 14, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1280776/000119380521001455/0001193805-21-001455-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.